Enhanced Provides Clinician-Led Access to Six New Peptides
Enhanced Group began offering clinician-led, prescription-only access to six new peptides (BPC-157, TB-500, KPV, MOTS-c, Epitalon, Semax) through its Live Enhanced telehealth platform, following the HHS policy announced October 28, 2026. The new peptides complement the existing GHK-Cu and Sermorelin offering, with compounding handled by state-licensed U.S. pharmacies using FDA-registered, CGMP-compliant ingredients.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.